Biocon Under Kiran Mazumdar Shaw

Rediff.com » News » Biocon Under Kiran Mazumdar Shaw

News for Biocon Under Kiran Mazumdar Shaw

News
Business

Actual number of COVID-19 cases 4 times higher: Kiran Mazumdar-Shaw

The actual coronavirus positive cases in the country will be at least four times the reported count, biotech entrepreneur Kiran Mazumdar-Shaw said on Thursday, citing large number of......

Electoral Bonds: The Quid Pro Quo Factor

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu. Illustration: Uttam Ghosh/Rediff.com The State Bank of India......

'No preparedness planning, no accountability, no action plan'

'This government did not have any plan for safety stocks of essential medicines.' IMAGE: Doctors attend to a patient suffering from COVID-19 inside the emergency room at the Safdarjung Hospital in......

Plasma therapy isn't proven treatment for COVID-19: Govt

The plasma therapy for treatment of coronavirus patients is at an experimental stage and it has the potential to cause life-threatening complications, the Union health ministry said on Tuesday,......

Why lack of testing must worry all of us

'Our government's claim that there are no undetected cases of infection that happened within our bustling cities because of exposure to infected international travellers are not credible,' notes......

Rupee Slide: Tough Times For Overseas Corporate Debt

Raising overseas debt has become prohibitively expensive due to the depreciating rupee. Photograph: Kind courtesy Jatinder Jeetu/Pixabay Indian companies' foreign borrowings plunged 20.2 per cent......

Start-up frenzy reflects a herd-like mentality: Kiran Mazumdar-Shaw

'I have learnt that gender discrimination obliterates when you succeed and overcome credibility and perception hurdles' India wasn't ready for a woman brewmaster in the 1970s when Kiran Mazumdar......

Kiran Mazumdar on Biocon's growth plans

After registering encouraging data from oral insulin trials, Biocon is looking to partner on this with global pharma firms. It is also reinventing research arms Syngene and Clinigene with more......

Jt drugs controller waives trial of Biocon drug; arrested

The CBI has arrested Joint Drugs Controller S Eswara Reddy for allegedly receiving a Rs 4 lakh bribe to waive the phase three clinical trial of the Insulin Aspart injection, a product of Biocon......

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......

Rediff News

Biocon Under Kiran Mazumdar Shaw

News for Biocon Under Kiran Mazumdar Shaw

Actual number of COVID-19 cases 4 times higher: Kiran Mazumdar-Shaw

Electoral Bonds: The Quid Pro Quo Factor

'No preparedness planning, no accountability, no action plan'

Plasma therapy isn't proven treatment for COVID-19: Govt

Why lack of testing must worry all of us

Rupee Slide: Tough Times For Overseas Corporate Debt

Start-up frenzy reflects a herd-like mentality: Kiran Mazumdar-Shaw

Kiran Mazumdar on Biocon's growth plans

Jt drugs controller waives trial of Biocon drug; arrested

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS